Delaware (State or other jurisdiction of incorporation or organization) |
000-31617 (Commission File Number) |
33-059-5156 (I.R.S. Employer Identification Number) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
Exhibit Index | ||||||||
EXHIBIT 10.56 |
(b) | On January 5, 2007, Ciphergen Biosystems, Inc. (the Company) received the resignation of James P. Merryweather, the Executive Vice President, Sales & Marketing of the Company whose role principally supported the Companys tools business. Concurrent with Dr. Merryweathers resignation, the Company entered into a consulting agreement (the Consulting Agreement) with him whereby Dr. Merryweather will continue to provide consulting services to the Company as requested for up to six months following his resignation, agree not to compete with the Company or solicit the services of the Companys employees, and provides a general release of claims in favor of the Company. In consideration, Dr. Merryweather will continue to receive compensation at his current base rate of pay during the term of the consulting period. |
10.56
|
Consulting Agreement by and between Ciphergen Biosystems, Inc. and James P. Merryweather dated January 5, 2007. |
Ciphergen Biosystems, Inc. (Registrant) |
||||
Date: January 11, 2007 | By: | /s/ Debra A. Young | ||
Debra A. Young | ||||
Chief Financial Officer | ||||